Sorry, your browser is out of date. To view this page correctly, please install a modern browser (Microsoft Edge, Firefox or Google Chrome).
SAI - Detailed view
Please log in as a company employee using your Swiss-Rx-Login. For further information please see the FAQ.
JEMPERLI Inf Konz 500 mg/10ml Amp 10 ml
Drug
Jemperli, Konzentrat zur Herstellung einer Infusionslösung
Endometriumkarzinom
07.16.1. – cytostatics
HAM – Human medicine
KOINF – Concentrate for solution for infusion
BT – biological medicines
A – Dispensed once only on prescription by a physician or veterinarian (A)
Z – approved
2/17/2022
12/21/2028
Dosage strength
Jemperli 500 mg/10 ml, Konzentrat zur Herstellung einer Infusionslösung
Endometriumkarzinom
01
Z – approved
Package
7680680230015
No information made available
A/R – Authorised / referenced
1 vial(s)
001
Z – approved
Declaration
Component
500 mg dostarlimabum
natrii citras dihydricus
acidum citricum monohydricum
arginini hydrochloridum
natrii chloridum
polysorbatum 80
aqua ad iniectabile
22.78 mg natrium
acidum citricum monohydricum
arginini hydrochloridum
natrii chloridum
polysorbatum 80
aqua ad iniectabile
22.78 mg natrium
Spezialitätenliste***
SL
-
-
5485.60
None
Yes
10%
No
Authorisation holder
7601001000674
GlaxoSmithKline AG
Talstrasse 3
3053 Münchenbuchsee (BE)
Talstrasse 3
3053 Münchenbuchsee (BE)
Date of revision of the text
3/19/2024
Please log in as a company employee using your Swiss-Rx-Login. For further information please see the FAQ.
Data source: Swissmedic, *authorisation holder, **Refdata foundation, ***FOPH.